Live Breaking News & Updates on ஆல்பர்ட் ஆய்வகங்கள்
Stay updated with breaking news from ஆல்பர்ட் ஆய்வகங்கள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ME Resource Corp ("MEC" or the "Company") (CNSX: MEC) (OTC: MEEXF) announced today that the Company has submitted an initial listing statement (the "Listing Statement") supporting its application for listing on the Canadian Securities Exchange ("CSE") in conjunction with its previously announced reverse take-over transaction ("RTO") with Albert Labs ("Albert Labs"). Albert Labs, a psychedelics drug developer using accelerated pathways to address urgent and unmet mental health needs across Europe ....
The Parent Company Appoints Seven Seasoned Experts To Social Equity Fund Advisory Committee The Parent Company (NEO: GRAM.U) (OTCQX:GRAMF) has appointed George Atallah, Marcia Dyson, Jeff Gray, Faith Leach, Carmen Perez, Mary Pryor and Angela Rye to serve on the advisory committee of its corporate venture capital social equity initiative. The newly formed equity fund seeks to discover the industry’s future entrepreneurs of color, offering them the capital and mentorship necessary to build generational wealth as part of a more equitable and diverse cannabis industry. “We established this fund to help break down the systematic barriers that Black and other minority entrepreneurs face as they seek to secure meaningful participation, growth, and leadership in this multi-billion-dollar industry,” said Desiree Perez, board member and chief social equity officer of The Parent Company. ....
A glance at some of the day s highlights from the Proactive Investors US and Canada newswires Your daily round-up from the world of Proactive Bioasis Technologies Inc (CVE:BTI) (OTCQB:BIOAF) has announced the publication of research validating the ability of its xB3 platform to cross the intact blood-brain barrier (BBB) and its localization in a variety of brain cell types. The company said research shows that the xB3 platform can cross intact BBB and enter intracellular organelles within neurons, glia and microglia in the brain. It said the data from a study published on June 2 in the Frontiers in Neuroscience provide evidence for the utility of xB3 peptide (previously known as MTfpep) as a platform technology for delivery of recombinant and chemically conjugated drug across the BBB. ....
Share: Professor Jo Neill and Parminder Singh bring psychopharmacology and IP protection & licensing expertise to a company pursuing psilocybin-based therapies VANCOUVER, BC, May 25, 2021 /CNW/ - Albert Labs, an innovative developer of psychedelics-based therapeutics addressing urgent and unmet mental health indications through Real World Evidence (RWE) studies in the UK and across Europe, is pleased to announce the chairs of its Clinical and Scientific Advisory Boards. The company welcomes Professor Jo Neill as the Chair of Albert Labs Clinical Advisory Board and Parminder Singh Chair of its Scientific Advisory Board. We are delighted to have such authority with Jo and Parminder, they bring a wealth of knowledge and expertise in each of their disciplines and we look forward to working with them in driving our Clinical and Scientific Advisory boards said Graeme McFarlane, Chief Commercial Officer of Albert Labs. ....